Difficulty identifying common smells such as lemon, banana and cinnamon may be the first sign of Alzheimer’s disease, according to a study that could lead to scratch-and-sniff tests to determine a person’s risk for the progressive brain disorder.
AstraZeneca Diabetes Drug Dapagliflozin Shows Promise
A new, experimental diabetes drug from AstraZeneca and Bristol-Myers Squibb called dapagliflozin, a Type 2 diabetes treatment developed showed some positive results, according to a presentation at the American Diabetes Association annual conference.
The companies reported that "no discontinuations due to adverse events and no serious adverse events" occurred. Furthermore, pre-clinical data also revealed that in tests on diabetic rats, the treatment significantly reduced plasma glucose levels–in some cases only two hours after a first dose.
Does Stimulant Treatment For ADHD Increase Risk Of Drug Abuse?
Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse.
The answer may depend on the age at which treatment is started and how long it lasts, say the authors of a new brain-imaging and behavioral study conducted in animals at the U.S. Department of Energy’s Brookhaven National Laboratory.
Doctor Says New Hormonal Therapy for Menopause Considered “Unsafe”
Bio-identical hormones have been a new alternative to the United States for women in menopause.
Although this form of hormonal treatment may be hope to many women, doctors say that it’s misleading. Bio-identical hormones may pose greater health risks than conventional therapy.
Addicted to the Internet? You may have ADHD
A study performed at Kaohsiung Medical University in Taiwan set out to investigate the links between emotional conditions such as anxiety, depression and ADHD and Internet addiction. Two thousand fourteen students, 1204 male and 910 female, were assessed for all of the above factors using a self-report questionnaire.
Lawsuit Charges Glaxo Failed to Warn of Diabetes Drug Risk
The widow and son of a Texas man who was taking a GlaxoSmithKline Plc diabetes drug at the time of his fatal heart attack has sued the drugmaker, claiming that it failed to warn of the drug’s heart risks, according to court papers.
The claim involves rosiglitazone, which is sold under the brand names Avandia and Advandamet. Investors have been bracing for a flood of litigation against Glaxo after a widely publicized medical report last month suggested that Avandia increases the risk of heart attack and death.
Pureed baby food is ‘unnatural’
Spoon-feeding babies pureed food could cause health problems later in life a Unicef childcare expert has warned.
FDA OKs Blood Pressure Drug
Patients who suffer from a rare disease that causes continuous high blood pressure in the arteries of the lungs received a new treatment choice Friday. The Food and Drug Administration said it approved Letairis to treat pulmonary arterial hypertension.
Kids and Junk Food Advertising Study
In a child’s buffet of food commercials, more than 40 percent of the dishes are candy, snacks and fast food. Nowhere to be found: fresh fruit, vegetables, poultry or seafood.
For years, health officials have warned that kids were being inundated with commercials about not-so-healthy foods. Now, researchers have put numbers to those warnings in the largest-ever study of commercials aimed at children.
Food allergies: One bite can be deadly
"He took a bite of the cookie and he said to his friend, ‘I shouldn’t have eaten that,’" said his mother. Severely allergic to peanuts, the 16-year-old from western Massachusetts made the dire mistake of not asking about the ingredients. Within minutes he developed a severe allergic reaction to the cookie, which contained peanuts.